Street Talk

Bell Potter kicks off equity raisings for Amplia, Elsight

Sarah Thompson, Kanika Sood and Emma Rapaport

Jul 21, 2025 – 12.28pm

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Already a subscriber?

Stockbroker Bell Potter hit the ground running on Monday, launching capital raisings for Israel-based defence tech player Elsight and drug developer Amplia Therapeutics.

Elsight, whose shares have risen more than 400 per cent year-to-date, was looking for about $60 million in fresh funds via single-tranche placement. Bells were offering the shares at $1.70 apiece, or an 11.7 per cent discount to the last close, according to a term sheet in front of listed equities investors.

Sarah Thompson has co-edited Street Talk since 2009, specialising in private equity, investment banking, M&A and equity capital markets stories. Prior to that, she spent 10 years in London as a markets and M&A reporter at Bloomberg and Dow Jones.

Kanika Sood is a journalist based in Sydney who writes for the Street Talk column.

Emma Rapaport is a co-editor of the Street Talk column. Prior to that, she was a markets reporter at The Australian Financial Review.